Diamide linked γ-cyclodextrin dimers as molecular-scale delivery systems for the medicinal pigment curcumin to prostate cancer cells

Molecular Pharmaceutics

Volumn 10, Issue 12, 2013, Pages 4481-4490

  Harada, Takaaki ^a   Giorgio, Lauren ^a   Harris, Tiffany J ^a   Pham, Duc Truc ^a   Ngo, Huy Tien ^a   Need, Eleanor F ^a   Coventry, Brendon J ^a   Lincoln, Stephen F ^a   Easton, Christopher J ^b   Buchanan, Grant ^a   Kee, Tak W ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

anticancer; biocompatibility; cell proliferation; cyclodextrin; drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; DIAMIDE; DIMER; GAMMA CYCLODEXTRIN DERIVATIVE; HEME OXYGENASE 1; N,N BIS(6A DEOXY GAMMA CYCLODEXTRIN 6A YL)SUCCINAMIDE; N,N BIS(6A DEOXY GAMMA CYCLODEXTRIN 6A YL)UREA; SUCCINIC ACID DERIVATIVE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FLUORESCENCE IMAGING; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROSTATE CANCER; SYNTHESIS; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; DIAMIDE; GAMMA-CYCLODEXTRINS; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; MALE; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 84889260559     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400309s     Document Type: Article

References (75)

1. Ferlay, J.; Shin, H.-R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D. M. Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 2010, 127, 2893-2917
2. Petrylak, D. P.; Tangen, C. M.; Hussain, M. H. A.; Lara, P. J.; Jones, J. A.; Taplin, M. E.; Burch, P. A.; Berry, D.; Moinpour, C.; Kohli, M. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer N. Engl. J. Med. 2004, 351, 1513-1520 (Pubitemid 39315318)
3. Jamieson, E. R.; Lippard, S. J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts Chem. Rev. 1999, 99, 2467-2498
4. Jung, Y. W.; Lippard, S. J. Direct Cellular Responses to Platinum-Induced DNA Damage Chem. Rev. 2007, 107, 1387-1407 (Pubitemid 46864967)
5. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Wu, M. S. Phase I Clinical Trial of Curcumin, A Chemopreventive Agent, in Patients with High-Risk or Pre-Malignant Lesions Anticancer Res. 2001, 21, 2895-2900
6. Aggarwal, B. B.; Kumar, A.; Bharti, A. C. Anticancer Potential of Curcumin: Preclinical and Clinical Studies Anticancer Res. 2003, 23, 363-398 (Pubitemid 36361976)
7. Goel, A.; Kunnumakkara, A. B.; Aggarwal, B. B. Curcumin as "Curecumin": From kitchen to clinic Biochem. Pharmacol. 2008, 75, 787-809
8. Kuttan, R.; Bhanumathy, P.; Nirmala, K.; George, M. C. Potential Anticancer Activity of Turmeric (Curcuma-longa) Cancer Lett. 1985, 29, 197-202 (Pubitemid 16175818)
9. Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A. B.; Aggarwal, B. B. Curcumin and Cancer: An "Old-Age" Disease with an "Age-Old" Solution Cancer Lett. 2008, 267, 133-164
10. Maheshwari, R. K.; Singh, A. K.; Gaddipati, J.; Srimal, R. C. Multiple Biological Activities of Curcumin: A Short Review Life Sci. 2006, 78, 2081-2087
11. Srimal, R. C.; Dhawan, B. N. Pharmacology of Diferuloyl Methane (Curcumin), a Nonsteroidal Antiinflammatory Agent J. Pharm. Pharmacol. 1973, 25, 447-452
12. Cole, G. M.; Lim, G. P.; Yang, F.; Teter, B.; Begum, A.; Ma, Q.; Harris-White, M. E.; Frautschy, S. A. Prevention of Alzheimer's Disease: Omega-3 Fatty Acid and Phenolic Anti-oxidant Interventions Neurobiol. Aging 2005, 26, 133-136
13. Egan, M. E.; Pearson, M.; Weiner, S. A.; Rajendran, V.; Rubin, D.; Glockner-Pagel, J.; Canny, S.; Du, K.; Lukacs, G. L.; Caplan, M. J. Curcumin, A Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects Science 2004, 304, 600-602 (Pubitemid 38541921)
14. Letchford, K.; Liggins, R.; Burt, H. Solubilization of Hydrophobic Drugs by Methoxy Poly(ethylene glycol)-block-polycaprolactone Diblock Copolymer Micelles: Theoretical and Experimental Data and Correlations J. Pharm. Sci. 2008, 97, 1179-1190
15. Kaminaga, Y.; Nagatsu, A.; Akiyama, T.; Sugimoto, N.; Yamazaki, T.; Maitani, T.; Mizukami, H. Production of Unnatural Glucosides of Curcumin with Drastically Enhanced Water Solubility by Cell Suspension Cultures of Catharanthus Roseus FEBS Lett. 2003, 555, 311-316 (Pubitemid 37486047)
16. Harada, T.; Pham, D.-T.; Leung, M. H. M.; Ngo, H. T.; Lincoln, S. F.; Easton, C. J.; Kee, T. W. Cooperative Binding and Stabilization of the Medicinal Pigment Curcumin by Diamide Linked γ-Cyclodextrin Dimers: A Spectroscopic Characterization J. Phys. Chem. B 2011, 115, 1268-1274
17. Leung, M. H. M.; Kee, T. W. Effective Stabilization of Curcumin by Association to Plasma Proteins: Human Serum Albumin and Fibrinogen Langmuir 2009, 25, 5773-5777
18. Wang, Y. J.; Pan, M. H.; Cheng, A. L.; Lin, L. I.; Ho, Y. S.; Hsieh, C. Y.; Lin, J. K. Stability of Curcumin in Buffer Solutions and Characterization of its Degradation Products J. Pharm. Biomed. Anal. 1997, 15, 1867-1876
19. Leung, M. H. M.; Colangelo, H.; Kee, T. W. Encapsulation of Curcumin in Cationic Micelles Suppresses Alkaline Hydrolysis Langmuir 2008, 24, 5672-5675
20. Mohanty, C.; Acharya, S.; Mohanty, A. K.; Dilnawaz, F.; Sahoo, S. K. Curcumin-Encapsulated MePEG/PCL Diblock Copolymeric Micelles: A Novel Controlled Delivery Vehicle for Cancer Therapy Nanomedicine 2010, 5, 433-449
21. Tang, H. D.; Murphy, C. J.; Zhang, B.; Shen, Y. Q.; Sui, M. H.; Van Kirk, E. A.; Feng, X. W.; Murdoch, W. J. Amphiphilic Curcumin Conjugate-Forming Nanoparticles as Anticancer Prodrug and Drug Carriers: in vitro and in vivo Effects Nanomedicine 2010, 5, 855-865
22. Wang, Z. F.; Leung, M. H. M.; Kee, T. W.; English, D. S. The Role of Charge in the Surfactant-Assisted Stabilization of the Natural Product Curcumin Langmuir 2010, 26, 5520-5526
23. Takahashi, M.; Uechi, S.; Takara, K.; Asikin, Y.; Wada, K. Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin J. Agric. Food Chem. 2009, 57, 9141-9146
24. Chen, C.; Johnston, T. D.; Jeon, H.; Gedaly, R.; McHugh, P. P.; Burke, T. G.; Ranjan, D. An in vitro Study of Liposomal Curcumin: Stability, Toxicity and Biological Activity in Human Lymphocytes and Epstein-Barr Virus-Transformed Human B-cells Int. J. Pharmaceutics 2009, 366, 133-139
25. Tønnesen, H. H.; Smistad, G.; Agren, T.; Karlsen, J. Studies on Curcumin and Curcuminoids XXIII. Effects of Curcumin on Liposomal Lipid-Peroxidation Int. J. Pharmaceutics 1993, 90, 221-228 (Pubitemid 23105157)
26. Mathur, A. B.; Gupta, V. Silk Fibroin-Derived Nanoparticles for Biomedical Applications Nanomedicine 2010, 5, 807-820
27. Yallapu, M. M.; Gupta, B. K.; Jaggi, M.; Chauhan, S. C. Fabrication of Curcumin Encapsulated PLGA Nanoparticles for Improved Therapeutic Effects in Metastatic Cancer Cells J. Colloid Interface Sci. 2010, 351, 19-29
28. Das, R. K.; Kasoju, N.; Bora, U. Encapsulation of Curcumin in Alginate-Chitosan-Pluronic Composite Nanoparticles for Delivery to Cancer Cells Nanomed.: Nanotechnol. Biol. Med. 2010, 6, 153-160
29. Sahu, A.; Kasoju, N.; Bora, U. Fluorescence Study of the Curcumin-Casein Micelle Complexation and its Application as a Drug Nanocarrier to Cancer Cells Biomacromolecules 2008, 9, 2905-2912
30. Barik, A.; Priyadarsini, K. I.; Mohan, H. Photophysical Studies on Binding of Curcumin to Bovine Serum Albumin Photochem. Photobiol. 2003, 77, 597-603
31. Esmaili, M.; Ghaffari, S. M.; Moosavi-Movahedi, Z.; Atri, M. S.; Sharifizadeh, A.; Farhadi, M.; Yousefi, R.; Chobert, J. M.; Haertle, T.; Moosavi-Movahedi, A. A. Beta Casein-Micelle as a Nano Vehicle for Solubility Enhancement of Curcumin; Food Industry Application Lwt-Food Sci. Technol. 2011, 44, 2166-2172
32. Yazdi, S. R.; Corredig, M. Heating of Milk Alters the Binding of Curcumin to Casein Micelles. A Fluorescence Spectroscopy Study Food Chem. 2012, 132, 1143-1149
33. Yang, L.; Alexandridis, P. Physicochemical Aspects of Drug Delivery and Release from Polymer-Based Colloids Curr. Opin. Colloid Interface Sci. 2000, 5, 132-143
34. FDA. gamma cyclodexrin.Food and Drug Administration; (2000) (updated Jun 30, 2012; cited Aug 3, 2012). Available from: http://www.accessdata.fda.gov/ scripts/fcn/fcnDetailNavigation.cfm?rpt=grasListing&id=46.
35. FDA. beta cyclodexrin. Food and Drug Administration; (2001) (updated Jun 30, 2012; cited Aug 3, 2012). Available from: http://www.accessdata.fda.gov/ scripts/fcn/fcnDetailNavigation.cfm?rpt=grasListing&id=74.
36. FDA. alpha cyclodexrin. Food and DrugAdministration; (2004) (updated Jun 30, 2012; cited Aug 3, 2012). Available from: http://www.accessdata.fda.gov/ scripts/fcn/fcnDetailNavigation.cfm?rpt=grasListing&id=155.
37. Szejtli, J. Introduction and General Overview of Cyclodextrin Chemistry Chem. Rev. 1998, 98, 1743-1753 (Pubitemid 128633435)
38. Hirayama, F.; Uekama, K. Cyclodextrin-Based Controlled Drug Release System Adv. Drug Deliver. Rev. 1999, 36, 125-141 (Pubitemid 29074480)
39. Thompson, D. O. Cyclodextrins-Enabling Excipients: Their Present and Future Use in Pharmaceuticals Crit. Rev. Ther. Drug 1997, 14, 1-104 (Pubitemid 27079973)
40. Pham, D. T.; Ngo, H. T.; Lincoln, S. F.; May, B. L.; Easton, C. J. Synthesis of C6(A)-to-C6(A) and C3(A)-to-C3(A) Diamide Linked Gamma-cyclodextrin Dimers Tetrahedron 2010, 66, 2895-2898
41. Marrocco, D. L.; Tilley, W. D.; Bianco-Miotto, T.; Evdokiou, A.; Scher, H. I.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Butler, L. M. Suberoylanilide Hydroxamic Acid (Vorinostat) Represses Androgen Receptor Expression and Acts Synergistically with an Androgen Receptor Antagonist to Inhibit Prostate Cancer Cell Proliferation Mol. Cancer Ther. 2007, 6, 51-60 (Pubitemid 46209918)
42. Uliasz, T. F.; Hewett, S. J. A Microtiter Trypan Blue Absorbance Assay for the Quantitative Determination of Excitotoxic Neuronal Injury in Cell Culture J. Neurosci. Methods 2000, 100, 157-163
43. Hayakawa, H.; Umehara, K.; Myrvik, Q. Oxidative Responses of Rabbit Alveolar Macrophages: Comparative Priming Activities of MIF/MAF, Sera, and Serum Components J. Leukoc. Biol. 1989, 45, 231-238 (Pubitemid 19086861)
44. Granato, A.; Gores, G.; Vilei, M. T.; Tolando, R.; Ferraresso, C.; Muraca, M. Bilirubin Inhibits Bile Acid Induced Apoptosis in Rat Hepatocytes Gut 2003, 52, 1774-1778 (Pubitemid 37510402)
45. Ueda, A.; Shimomura, M.; Ikeda, M.; Yamaguchi, R.; Tanishita, K. Effect of Glycocalyx on Shear-Dependent Albumin Uptake in Endothelial Cells Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H2287-H2294
46. Bang, Y. J.; Kim, S. J.; Danielpour, D.; Oreilly, M. A.; Kim, K. Y.; Myers, C. E.; Trepel, J. B. Cyclic-AMP Induces Transforming Growth-factor-beta-2 Gene-expression and Growth Arrest in the Human and Rogen-independent Prostate Carcinoma Cell Line PC-3 Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3556-3560
47. Bang, Y. J.; Pirnia, F.; Fang, W. G.; Kang, W. K.; Sartor, O.; Whitesell, L.; Ha, M. J.; Tsokos, M.; Sheahan, M. D.; Nguyen, P. Terminal Neuroendocrine Differentiation of Human Prostate Carcinoma Cells in Response to Increased Intracellular Cyclic AMP Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 5330-5334 (Pubitemid 24174320)
48. Calvert, R. C.; Shabbir, M.; Thompson, C. S.; Mikhailidis, D. P.; Morgan, R. J.; Burnstock, G. Immunocytochemical and Pharmacological Characterisation of P2-purinoceptor-mediated Cell Growth and Death in PC-3 Hormone Refractory Prostate Cancer Cells Anticancer Res. 2004, 24, 2853-2859 (Pubitemid 39407158)
49. Jiang, Q.; Wong, J.; Fyrst, H.; Saba, J. D.; Ames, B. N. γ-Tocopherol or Combinations of Vitamin E Forms Induce Cell Death in Human Prostate Cancer Cells by Interrupting Sphingolipid Synthesis Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17825-17830 (Pubitemid 40051971)
50. Paschka, A. G.; Butler, R.; Young, C. Y. F. Induction of Apoptosis in Prostate Cancer Cell Lines by the Green Tea Component, (-)-epigallocatechin-3- gallate Cancer Lett. 1998, 130, 1-7 (Pubitemid 28425331)
51. Rose, D. P.; Connolly, J. M. Effects of Fatty Acids and Eicosanoid Synthesis Inhibitors on the Growth of 2 Human Prostate Cancer Cell Lines Prostate 1991, 18, 243-254
52. Thangapazham, R. L.; Shaheduzzaman, S.; Kim, K. H.; Passi, N.; Tadese, A.; Vahey, M.; Dobi, A.; Srivastava, S.; Maheshwari, R. K. Androgen Responsive and Refractory Prostate Cancer Cells Exhibit Distinct Curcumin Regulated Transcriptome Cancer Biol. Ther. 2008, 7, 1429-1437
53. McNally, S. J.; Harrison, E. M.; Ross, J. A.; Garden, O. J.; Wigmore, S. J. Curcumin Induces Heme Oxygenase 1 through Generation of Reactive Oxygen Species, p38 Activation and Phosphatase Inhibition Int. J. Mol. Med. 2007, 19, 165-172
54. Motterlini, R.; Foresti, R.; Bassi, R.; Green, C. J. Curcumin, an Antioxidant and Anti-inflammatory Agent, Induces Heme Oxygenase-1 and Protects Endothelial Cells against Oxidative Stress Free Radic. Biol. Med. 2000, 28, 1303-1312 (Pubitemid 30417475)
55. Aggarwal, B. B. Prostate Cancer and Curcumin-Add Spice to Your Life Cancer Biol. Ther. 2008, 7, 1438-1442
56. Thangapazham, R. L.; Shaheduzzaman, S. M.; Kim, K. H.; Passi, N.; Dobi, A.; Srivastava, S.; Maheshwari, R. Androgen Responsive and Refractory Prostate Cancer Cells Exhibit Distinct Curcumin Regulated Transcriptome J. Urol. 2008, 179, 190-191
57. Ravindran, J.; Subbaraju, G. V.; Ramani, M. V.; Sung, B. Y.; Aggarwal, B. B. Bisdemethylcurcumin and Structurally Related Hispolon Analogues of Curcumin Exhibit Enhanced Prooxidant, Anti-proliferative and Anti-inflammatory Activities in vitro Biochem. Pharmacol. 2010, 79, 1658-1666
58. Shankar, S.; Chen, Q.; Sarva, K.; Siddiqui, I.; Srivastava, R. K. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis J. Mol. Signal. 2007, 2, 1-14
59. Bachmeier, B. E.; Mirisola, V.; Romeo, F.; Generoso, L.; Esposito, A.; Dell'Eva, R.; Blengio, F.; Killian, P. H.; Albini, A.; Pfeffer, U. Reference Profile Correlation Reveals Estrogen-like Trancriptional Activity of Curcumin Cell. Physiol. Biochem. 2010, 26, 471-482
60. Chirnomas, D.; Taniguchi, T.; de la Vega, M.; Vaidya, A. P.; Vasserman, M.; Hartman, A. R.; Kennedy, R.; Foster, R.; Mahoney, J.; Seiden, M. V. Chemosensitization to Cisplatin by Inhibitors of the Fanconi Anemia/BRCA Pathway Mol. Cancer Ther. 2006, 5, 952-961 (Pubitemid 43724595)
61. Hour, T.-C.; Chen, J.; Huang, C.-Y.; Guan, J.-Y.; Lu, S.-H.; Pu, Y.-S. Curcumin Enhances Cytotoxicity of Chemotherapeutic Agents in Prostate Cancer Cells by Inducing p21WAF1/CIP1 and C/EBPβ Expressions and Suppressing NF-κB Activation Prostate 2002, 51, 211-218 (Pubitemid 34492642)
62. Mukhopadhyay, A.; Bueso-Ramos, C.; Chatterjee, D.; Pantazis, P.; Aggarwal, B. B. Curcumin Downregulates Cell Survival Mechanisms in Human Prostate Cancer Cell Lines Oncogene 2001, 20, 7597-7609 (Pubitemid 33111860)
63. Syrovets, T.; Gschwend, J. E.; Buchele, B.; Laumonnier, Y.; Zugmaier, W.; Genze, F.; Simmet, T. Inhibition of IκB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-Independent PC-3 Prostate Cancer Cells in vitro and in vivo J. Biol. Chem. 2005, 280, 6170-6180 (Pubitemid 40280102)
64. Mukerjee, A.; Vishwanatha, J. K. Formulation, Characterization and Evaluation of Curcumin-loaded PLGA Nanospheres for Cancer Therapy Anticancer Res. 2009, 29, 3867-3875
65. Janda, K. D.; Schloeder, D.; Benkovic, S. J.; Lerner, R. A. Induction of an Antibody that Catalyzes the Hydrolysis of an Amide Bond Science 1988, 241, 1188-1191
66. Jencks, W. P. Catalysis in Chemistry and Enzymology; McGraw-Hill: New York, 1969.
67. Satterth, A. C.; Jencks, W. P. Mechanism of Aminolysis of Acetate Esters J. Am. Chem. Soc. 1974, 96, 7018-7031
68. Fersht, A. Enzyme Structure and Mechanism; W. H. Freeman & Company: London, 1985.
69. Dhule, S. S.; Penfornis, P.; Frazier, T.; Walker, R.; Feldman, J.; Tan, G.; He, J.; Alb, A.; John, V.; Pochampally, R. Curcumin-Loaded γ-Cyclodextrin Liposomal Nanoparticles as Delivery Vehicles for Osteosarcoma Nanomed.: Nanotechnol. Biol. Med. 2012, 8, 440-451
70. Yadav, V. R.; Prasad, S.; Kannappan, R.; Ravindran, J.; Chaturvedi, M. M.; Vaahtera, L.; Parkkinen, J.; Aggarwal, B. B. Cyclodextrin-Complexed Curcumin Exhibits Anti-inflammatory and Antiproliferative Activities Superior to those of Curcumin through Higher Cellular Uptake Biochem. Pharmacol. 2010, 80, 1021-1032
71. Yallapu, M. M.; Jaggi, M.; Chauhan, S. C. β-Cyclodextrin-Curcumin Self-assembly Enhances Curcumin Delivery in Prostate Cancer Cells Colloids Surf., B 2010, 79, 113-125
72. Chignell, C. F.; Bilskj, P.; Reszka, K. J.; Motten, A. G.; Sik, R. H.; Dahl, T. A. Spectral and Photochemical Properties of Curcumin Photochem. Photobiol. 1994, 59, 295-302
73. Khopde, S. M.; Indira Priyadarsini, K.; Palit, D. K.; Mukherjee, T. Effect of Solvent on the Excited-State Photophysical Properties of Curcumin Photochem. Photobiol. 2000, 72, 625-631
74. Anand, P.; Nair, H. B.; Sung, B. K.; Kunnumakkara, A. B.; Yadav, V. R.; Tekmal, R. R.; Aggarwal, B. B. Design of Curcumin-Loaded PLGA Nanoparticles Formulation with Enhanced Cellular Uptake, and Increased Bioactivity in vitro and Superior Bioavailability in vivo Biochem. Pharmacol. 2010, 79, 330-338
75. Garcia-Rio, L.; Mendez, M.; Paleo, A. R.; Sardina, F. J. New Insights in Cyclodextrin: Surfactant Mixed Systems from the Use of Neutral and Anionic Cyclodextrin Derivatives J. Phys. Chem. B 2007, 111, 12756-12764 (Pubitemid 350136463)